Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the number.
Washout: how long is long enough, and for what purpose posts 61–71
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Taking post #62 at face value and following it one step further.
Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein. That is relevant to understanding how much free drug is available.
Coming back to post #64, because the follow-up matters more than the original answer.
Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule pharmacology mostly do not apply.
The bit of washout that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.
This follows post #67 rather than contradicting it.
Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the number.
If anyone has run this properly I would rather read that than my own guess.
Collapsed as off-topic by two members at trust level 3 or above
Something worth flagging about washout: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.
Confirming post #67 from a second method, which matters more than confirming it from a second person.
Where the washout discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein. That is relevant to understanding how much free drug is available.
This topic was referenced in
- Half-life, steady state, and accumulation worked throughPharmacology › Pharmacokinetics · 130 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
|
+11 | 15 | 43k | 2mo |
|
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 32k | 8mo | |
|
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Peak-to-trough ratio,…
|
+57 | 61 | 708 | 1d |
|
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
|
+110 | 126 | 14k | 4mo |
|
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about Washout, deliberately narrow, because the…
|
+128 | 139 | 3k | 3mo |
Related topics — sharing the tags semaglutide, missed dose, worked example
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A 10 mg vial reconstituted three different ways, compared — the long version
A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Asking about 10 mg vial reconstituted three directly, because…
|
+146 | 158 | 47k | 9mo |
|
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title and the context underneath, in the order the…
|
2 | 16k | 30d | |
|
Reading U-100 graduations, with a conversion table — one year on
Reading U-100 graduations, with a conversion table — one year on Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on…
|
+3 | 7 | 662 | 4mo |
|
Subcutaneous absorption kinetics and site differences
Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. Asking about subcutaneous absorption kinetics and site directly,…
|
+15 | 19 | 3.9k | 12mo |
|
The mass-error checker and its intended scope
The mass-error checker and its intended scope Writing it up because I had to work it out twice and would rather nobody else did. Proposing that mass-error checker deserves a maintained page rather than a…
|
+149 | 167 | 42k | 2y |